SOUTH SAN FRANCISCO, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc., (Nasdaq: MGRM) announced that it will hold a conference
call on Thursday, February 7, 2008 at 4:30 p.m. (Eastern Time) to discuss
fourth quarter 2007 financial results and to discuss the outlook for 2008.
The call will be hosted by Mr. William D. Young, Chairman and CEO of
Monogram.
To participate in the live teleconference, please call (877) 545-1409,
or (719) 325-4855 for international callers, fifteen minutes before the
conference begins. Live audio of the call will be simultaneously broadcast
over the Internet and will be available to members of the news media,
investors and the general public. Following the live broadcast, a replay of
the call will also be available at (888) 203-1112 or (719) 457-0820 for
international callers, through Thursday, February 21, 2008. The replay
passcode is 3649403. Access to live and archived audio of the conference
call will be available by following the appropriate links at
http://www.monogrambio.com and clicking on the Investor Relations link.
The information provided on the teleconference is only accurate at the
time of the conference call, and Monogram will take no responsibility for
providing updated information except as required by law.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering,
developing and marketing innovative products to guide and improve treatment
of serious infectious diseases and cancer. The Company's products are
designed to help doctors optimize treatment regimens for their patients
that lead to better outcomes and reduced costs. The Company's technology is
also being used by numerous biopharmaceutical companies to develop new and
improved antiviral therapeutics and vaccines as well as targeted cancer
therapeutics. More information about the Company and its technology can be
found on its web site at http://www.monogrambio.com.
contacts: Alfred G. Merriweather Jeremiah Hall
Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700
amerriweather@monogrambio.com jeremiah.hall@fkhealth.com
SOURCE Monogram Biosciences, Inc.
 back to top
Related links:
http://www.monogrambio.com
CONTACT:
Alfred G. Merriweather, Chief Financial
Officer of Monogram Biosciences, Inc., +1-650-624-4576,
amerriweather@monogrambio.com; Jeremiah Hall of Feinstein Kean
Healthcare, +1-415-677-2700, jeremiah.hall@fkhealth.com, for
Monogram Biosciences, Inc.
|
